In support of "Step-Up Therapy" for gastroesophageal reflux disease [16]

American Journal of Gastroenterology

Volumn 97, Issue 2, 2002, Pages 503-504

  Beck, Ivan T ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b HOTEL DIEU HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LETTER; PATIENT SATISFACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036182051     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04079-5     Document Type: Letter

References (7)

1. Management of heartburn in a large, randomized, community-based study: Comparison of four therapeutic strategies
2. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine
3. Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis
4. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis
5. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: A randomized, double-blind, parallel, and multicentre study
6. Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: A clinical database analysis
7. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis